Micro Emerging Active

SYNH stock up 72% on $8M sale, reduced stake by Kynam Capital

Score
0.3
Velocity
▲ 0.0
Articles
3
Sources
1

Summary

An article belongs to this narrative if it discusses changes in institutional holdings of Syndax Pharmaceuticals.

Related Articles

Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges

Nasdaq · Mar 22, 2026
Mixed

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a …

Nasdaq · Mar 22, 2026
Mixed

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems …

Nasdaq · Mar 21, 2026
Neutral

Sources

Structure Therapeutics Slides 28% This Year as $6 Million Stake … Nasdaq
This $116 Million Buy Joins a 360% Stock Run and … Nasdaq
Biotech Stock Up 72% Sees $8 Million Sale, but Here's … Nasdaq

Timeline

Last Updated Mar 21, 2026